Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Late Endocrine and Metabolic Sequelae and Long-Term Monitoring of Classical Hodgkin Lymphoma and Diffuse Large B-Cell Lymphoma Survivors: A Systematic Review by the Fondazione Italiana Linfomi.
Di Molfetta S, Daniele A, Gerardi C, Allocati E, Minoia C, Loseto G, Giorgino F, Guarini A, De Sanctis V. Di Molfetta S, et al. Among authors: giorgino f. Cancers (Basel). 2022 Mar 10;14(6):1439. doi: 10.3390/cancers14061439. Cancers (Basel). 2022. PMID: 35326591 Free PMC article. Review.
Structured self-monitoring of blood glucose is associated with more appropriate therapeutic interventions than unstructured self-monitoring: A novel analysis of data from the PRISMA trial.
Di Molfetta S, Bosi E, Ceriello A, Cucinotta D, Tiengo A, Scavini M, Piccolo C, Bonizzoni E, Acmet E, Giorgino F; PRISMA STUDY GROUP. Di Molfetta S, et al. Among authors: giorgino f. Diabetes Res Clin Pract. 2021 Nov;181:109070. doi: 10.1016/j.diabres.2021.109070. Epub 2021 Sep 27. Diabetes Res Clin Pract. 2021. PMID: 34592390 Free article.
A telemedicine-based approach with real-time transmission of blood glucose data improves metabolic control in insulin-treated diabetes: the DIAMONDS randomized clinical trial.
Di Molfetta S, Patruno P, Cormio S, Cignarelli A, Paleari R, Mosca A, Lamacchia O, De Cosmo S, Massa M, Natalicchio A, Perrini S, Laviola L, Giorgino F. Di Molfetta S, et al. Among authors: giorgino f. J Endocrinol Invest. 2022 Sep;45(9):1663-1671. doi: 10.1007/s40618-022-01802-w. Epub 2022 Apr 27. J Endocrinol Invest. 2022. PMID: 35476320 Free PMC article. Clinical Trial.
Evaluation of a digital tool supporting therapeutic decision making for the personalized management of patients with type 2 diabetes not treated with insulin: A pilot study.
Di Molfetta S, Laviola L, Natalicchio A, Leonardini A, Cignarelli A, Bonizzoni E, Acmet E, Giorgino F. Di Molfetta S, et al. Among authors: giorgino f. Diabetes Res Clin Pract. 2023 Sep;203:110836. doi: 10.1016/j.diabres.2023.110836. Epub 2023 Jul 20. Diabetes Res Clin Pract. 2023. PMID: 37478979 Free article. Clinical Trial.
Polybrominated Diphenyl Ethers (PBDEs) and Human Health: Effects on Metabolism, Diabetes and Cancer.
Renzelli V, Gallo M, Morviducci L, Marino G, Ragni A, Tuveri E, Faggiano A, Mazzilli R, Natalicchio A, Zatelli MC, Montagnani M, Fogli S, Giuffrida D, Argentiero A, Danesi R, D'Oronzo S, Gori S, Franchina T, Russo A, Monami M, Sciacca L, Cinieri S, Colao A, Avogaro A, Di Cianni G, Giorgino F, Silvestris N. Renzelli V, et al. Among authors: giorgino f. Cancers (Basel). 2023 Aug 24;15(17):4237. doi: 10.3390/cancers15174237. Cancers (Basel). 2023. PMID: 37686512 Free PMC article. Review.
Glucometabolic outcomes of GLP-1 receptor agonist-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis.
Caruso I, Di Gioia L, Di Molfetta S, Cignarelli A, Palmer SC, Natale P, Strippoli GFM, Perrini S, Natalicchio A, Laviola L, Giorgino F. Caruso I, et al. Among authors: giorgino f. EClinicalMedicine. 2023 Sep 12;64:102181. doi: 10.1016/j.eclinm.2023.102181. eCollection 2023 Oct. EClinicalMedicine. 2023. PMID: 37719418 Free PMC article.
365 results